Literature DB >> 11733222

Animal models for respiratory chain disease.

N G Larsson1, P Rustin.   

Abstract

Elucidation of the pathogenesis in respiratory chain diseases is of great importance for developing specific treatments. The limitations inherent to the use of patient material make studies of human tissues often difficult and the mouse has therefore emerged as a suitable model organism for studies of respiratory chain diseases. In this review, we present an overview of the field and discuss in depth a few examples of animal models reproducing pathology of human disease with primary and secondary respiratory chain involvement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733222     DOI: 10.1016/s1471-4914(01)02167-0

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  17 in total

Review 1.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

2.  Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice.

Authors:  Henna Tyynismaa; Katja Peltola Mjosund; Sjoerd Wanrooij; Ilse Lappalainen; Emil Ylikallio; Anu Jalanko; Johannes N Spelbrink; Anders Paetau; Anu Suomalainen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

3.  Suppressing Mitochondrial Respiration Is Critical for Hypoxia Tolerance in the Fetal Growth Plate.

Authors:  Qing Yao; Mohd Parvez Khan; Christophe Merceron; Edward L LaGory; Zachary Tata; Laura Mangiavini; Jiarui Hu; Krishna Vemulapalli; Navdeep S Chandel; Amato J Giaccia; Ernestina Schipani
Journal:  Dev Cell       Date:  2019-05-16       Impact factor: 12.270

4.  Hypersensitivity to oxygen and shortened lifespan in a Drosophila mitochondrial complex II mutant.

Authors:  David W Walker; Petr Hájek; Julien Muffat; Dan Knoepfle; Stephanie Cornelison; Giuseppe Attardi; Seymour Benzer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-20       Impact factor: 11.205

5.  Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy.

Authors:  Nicholas Joza; Gavin Y Oudit; Doris Brown; Paule Bénit; Zamaneh Kassiri; Nicola Vahsen; Loralyn Benoit; Mikin M Patel; Karin Nowikovsky; Anne Vassault; Peter H Backx; Teiji Wada; Guido Kroemer; Pierre Rustin; Josef M Penninger
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 6.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

7.  AIF deficiency compromises oxidative phosphorylation.

Authors:  Nicola Vahsen; Céline Candé; Jean-Jacques Brière; Paule Bénit; Nicholas Joza; Nathanael Larochette; Pier Giorgio Mastroberardino; Marie O Pequignot; Noelia Casares; Vladimir Lazar; Olivier Feraud; Najet Debili; Silke Wissing; Silvia Engelhardt; Frank Madeo; Mauro Piacentini; Josef M Penninger; Hermann Schägger; Pierre Rustin; Guido Kroemer
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 8.  Mitochondrial disorders: clinical presentation and diagnostic dilemmas.

Authors:  J A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression.

Authors:  Benoit R Gauthier; Andreas Wiederkehr; Mathurin Baquié; Chunhua Dai; Alvin C Powers; Julie Kerr-Conte; François Pattou; Raymond J MacDonald; Jorge Ferrer; Claes B Wollheim
Journal:  Cell Metab       Date:  2009-08       Impact factor: 27.287

10.  Mouse models of oxidative phosphorylation dysfunction and disease.

Authors:  Uma D Vempati; Alessandra Torraco; Carlos T Moraes
Journal:  Methods       Date:  2008-10-10       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.